Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117
单独使用阿扎胞苷或与来那度胺或伏立诺他联合使用治疗高风险骨髓增生异常综合征和慢性粒单核细胞白血病的随机 II 期研究:北美组间研究 SWOG S1117
期刊:Journal of Clinical Oncology
影响因子:42.1
doi:10.1200/JCO.2015.66.2510
Mikkael A Sekeres, Megan Othus, Alan F List, Olatoyosi Odenike, Richard M Stone, Steven D Gore, Mark R Litzow, Rena Buckstein, Min Fang, Diane Roulston, Clara D Bloomfield, Anna Moseley, Aziz Nazha, Yanming Zhang, Mario R Velasco, Rakesh Gaur, Ehab Atallah, Eyal C Attar, Elina K Cook, Alyssa H Cull,